Administrative Core
Administrative Core
批准号:
10707072
负责人:
Sridevi V. Sarma
金额:
$83.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-30 至 2027-06-30
关键词:
AreaArticulationBudgetsBusinessesChairpersonCollaborationsCommittee MembersCommunicationDataDevelopmentDreamsEcosystemElementsEnsureEquityEvaluationFundingGoalsGoverning BoardHuman ResourcesIndividualInstitutionLeadLeadershipMedicalMethodsNeeds AssessmentNeurologicNeurologyOutcomePersonsProcessResourcesScientific Advances and AccomplishmentsSocietiesStrategic PlanningTechnologyUnited States National Institutes of HealthUniversitiesWorkclinical translationimprovedinnovationinsightmeetingsmemberoutreachprogramsresponsesuccess
中文摘要
项目摘要
NeuroTech Harbor(NTH)的行政核心(AC)将指导,协调和领导外展,
评估、创新和资源核心,以有效实现以下目标:(一)在以下方面成为国家领导者:
支持和开发现实世界的解决方案,以神经问题,并确保它这样做,在一个
以反映我们Equitech在参与人员和项目中的包容性和公平性的价值观的方式
支持. (ii)作为联邦基金的优秀管理者,为NIH和社会实现最大回报,
大.咨询委员会将由理事会、指导委员会和咨询委员会组成。AC将服务于
作为一个中央领导团队,将不断评估,完善和改进NTH流程,以实现更好的
结果新太医院顾问委员会将达致以下目标:(目标1)确保卓越的管治,
管理在NTH。(Aim 2)协调所有NTH核心与指导委员会(SC)的互动,
咨询委员会(AB)和顾问网络。(Aim 3)筹备由新天地选出的优秀创新项目
为NIH的资金考虑,并确保资助项目的成功。(Aim(4)积极沟通
实践并在BluePrint Hub联盟中进行协作。
我们已经组建了一个由NTH PI领导的管理委员会,担任每个核心的董事。开国
NTH的机构合作伙伴,理事会将由联合主席Dean Schlesinger共同领导,
JHU和来自霍华德的教务长Wutoh博士。董事会将确保NTH的Equitech方法
是每个核心计划中所有决策和行动的前沿和中心。AC也将作为最终的
仲裁冲突,并采取行动,以最大限度地提高NTH,核心和子项目的成功可能性。而
核心董事将单独管理每个核心的预算、人员、流程和目标,AC将
作为所有核心的中央协调员,接受SC和AB的定期输入和监督。AC将
考虑适当的常设委员会成员,以(1)外展核心需求评估和国家技术小组的招标,以及(2)
与评估核心一起进行审查,以确保选择最具影响力的创新项目。
AC团队将召开年度理事会会议,与主要AB成员一起,
在质量、效率、成果和应对不断变化的
医疗需求,技术突破和神经病学领域的科学进步的景观。
AC将协调与外部专家顾问网络的联系,这些专家涵盖广泛的专业知识
(早期技术、临床翻译或业务开发),以组建梦想技术团队,
每个创新项目创新者核心将为创新者提供必要的指导和资源
为最佳的现实世界影响构建解决方案。AC将负责协调与
NIH Blueprint(BP)计划工作人员进行战略规划。此外,AC将与每个核心的工作人员合作,
收集、分析并向BP网络传播我们的成果和最佳实践。
英文摘要
PROJECT SUMMARY ADMINISTRATIVE CORE
The Administrative Core (AC) of NeuroTech Harbor (NTH) will direct, coordinate, and lead the Outreach,
Evaluation, Innovator, and Resource Cores to efficiently achieve the following goals: (i) Be a national leader in
the support and development of real-world solutions to neurological problems and ensure that it does so in a
way that reflects our Equitech values of inclusivity and equity in both the people involved and the projects it
supports. (ii) Act as an excellent steward of federal funds to achieve maximum return for NIH and society at
large. The AC will consist of the Governing Board, Steering Committee, and Advisory Board. The AC will serve
as a central leadership team that will continually assess, refine, and improve NTH processes to achieve better
results. NTH's AC will accomplish the following aims: (Aim 1) To ensure excellence in Governance and
Management at NTH. (Aim 2) To coordinate all NTH Core interactions with the Steering Committee (SC),
Advisory Board (AB), and Consultant Network. (Aim 3) To prepare NTH-selected meritorious innovation projects
for NIH funding consideration and ensure success of funded projects. (Aim 4) To actively communicate best
practices and collaborate across the BluePrint Hub consortium.
We have assembled a Governing Board led by NTH PIs serving as Directors of each Core. As the founding
institutional partners of NTH, the Governing Board will be led jointly by Co-Chairmen Dean Schlesinger from
JHU and Provost Dr. Wutoh from Howard. The Governing Board will ensure that the Equitech approach of NTH
is front and center to all decisions and actions in each individual Core's plans. The AC will also act as the final
arbiter of conflicts and take action to maximize likelihood of success for NTH, Cores, and subprojects. While
Core Directors will separately manage the budgets, personnel, processes, and goals for each Core, the AC will
act as a central coordinator for all Cores to receive regular input and oversight from the SC and AB. The AC will
consider appropriate SC members for (1) Outreach Core needs assessments and NTH solicitations, and (2)
reviews with the Evaluation Core to ensure the highest impact innovation projects are selected.
The AC team will convene an annual Governing Board meeting with key AB members to continuously identify
areas of improvement in quality, efficiency, outcomes, and responsiveness in response to the changing
landscape of medical needs, technological breakthroughs, and scientific advancements in the neurology space.
The AC will coordinate access to an external Consultant Network of experts who span a broad range of expertise
(early-stage technology, clinical translation, or business development) to assemble the Dream Tech Team for
each innovator project. In the Innovator Core will support innovators with the guidance and resources necessary
for building solutions for optimal real-world impact. The AC will be responsible for coordinating interactions with
NIH BluePrint (BP) program staff on strategic planning. In addition, the AC will work with each Core's staff to
collect, analyze, and disseminate our outcomes and best practices to the BP network.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EEG Biomarkers Derived from Dynamical Network Models Enable Rapid Paths to Accurate Diagnosis and Effective Treatment of Epilepsy
-
批准号:10665213
-
项目类别:
-
资助金额:$48.01万
-
财政年份:2023
-
负责人:Sridevi V. Sarma
-
依托单位:
Using Feedback Control to Suppress Seizure Genesis in Epilepsy
-
批准号:9920327
-
项目类别:
-
资助金额:$0.83万
-
财政年份:2019
-
负责人:Sridevi V. Sarma
-
依托单位:
CRCNS: MOVE!-MOdeling of fast Movement for Enhancement via neuroprosthetics
-
批准号:10611557
-
项目类别:
-
资助金额:$1.35万
-
财政年份:2018
-
负责人:Sridevi V. Sarma
-
依托单位:
CRCNS: MOVE!-MOdeling of fast Movement for Enhancement via neuroprosthetics
-
批准号:10352692
-
项目类别:
-
资助金额:$6.77万
-
财政年份:2018
-
负责人:Sridevi V. Sarma
-
依托单位:
CRCNS: MOVE!-MOdeling of fast Movement for Enhancement via neuroprosthetics
-
批准号:9898497
-
项目类别:
-
资助金额:$34.03万
-
财政年份:2018
-
负责人:Sridevi V. Sarma
-
依托单位:
CRCNS: MOVE!-MOdeling of fast Movement for Enhancement via neuroprosthetics
-
批准号:10385747
-
项目类别:
-
资助金额:$33.26万
-
财政年份:2018
-
负责人:Sridevi V. Sarma
-
依托单位:
CRCNS: Towards Pain Control: Synergizing Computational and Biological Approaches
-
批准号:9323301
-
项目类别:
-
资助金额:$39.6万
-
财政年份:2016
-
负责人:Sridevi V. Sarma
-
依托单位:
CRCNS: Towards Pain Control: Synergizing Computational and Biological Approaches
-
批准号:9242340
-
项目类别:
-
资助金额:$39.49万
-
财政年份:2016
-
负责人:Sridevi V. Sarma
-
依托单位:
海外基金